| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | United Kingdom | 4 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | Hong Kong | 2 | |
| #7 | Republic of Korea | 2 | |
| #8 | Peru | 2 | |
| #9 | Australia | 1 | |
| #10 | Chile | 1 | |
| #11 | India | 1 | |
| #12 | Luxembourg | 1 | |
| #13 | Mexico | 1 | |
| #14 | Russian Federation | 1 | |
| #15 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Micro-structure and nano-technology | |
| #5 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Peptides | |
| #5 | Nanostructure applications | |
| #6 | Enzymes | |
| #7 | Measuring microorganism processes | |
| #8 | Sugars | |
| #9 | Fermentation | |
| #10 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Williams Peter A | 6 |
| #2 | Richardson Helen | 6 |
| #3 | Auger Kurt R | 5 |
| #4 | Sood Anil K | 5 |
| #5 | Bottsford-Miller Justin | 4 |
| #6 | Gupta Manish K | 3 |
| #7 | Gossett Augustus Campbell | 3 |
| #8 | Kumar Rakesh | 2 |
| #9 | Krauss Achim Hans-Peter | 2 |
| #10 | Gossets Augustus Campbell | 2 |
| Publication | Filing date | Title |
|---|---|---|
| GB201811846D0 | Chemical compounds | |
| GB201711779D0 | Delivery | |
| GB201710620D0 | Targeted protein degradation | |
| WO2017064564A2 | Therapeutic regimens for treating psoriatic arthritis with an anti-ccl20 antibody | |
| WO2017006272A1 | Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditions | |
| LU92549I2 | An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE; | |
| KR20140011322A | Combinations | |
| EP2512242A1 | Novel compounds |